Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -2.50 | -0.82% | 302.50 | 74,112 | 09:00:22 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 300.00 | 305.00 | 305.00 | 302.50 | 305.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | 41.93M | 6.49M | 0.1361 | 22.23 | 145.46M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 14:31:13 | O | 823 | 301.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 26/3/2025 | 10:30 | UK RNS | Tristel PLC Director/PDMR Shareholding |
| 18/3/2025 | 14:39 | UK RNS | Tristel PLC Holding(s) in Company |
| 24/2/2025 | 11:37 | ALNC |  Tristel ups dividend on interim profit growth, remains focused on US |
| 24/2/2025 | 07:00 | UK RNS | Tristel PLC Unaudited Interim Results |
| 07/2/2025 | 07:00 | UK RNS | Tristel PLC Exercise of Share Options and Total Voting Rights |
| 23/1/2025 | 07:00 | UK RNS | Tristel PLC Director Option Grant |
| 13/1/2025 | 07:00 | UK RNS | Tristel PLC Confirmation of Interim Results |
| 16/12/2024 | 14:45 | UK RNS | Tristel PLC Result of AGM |
| 16/12/2024 | 07:00 | UK RNS | Tristel PLC AGM Statement and Notice of Interim Results |
| 22/11/2024 | 10:30 | UK RNS | Tristel PLC Notice of AGM & Posting of Annual Report &Accounts |
Tristel (TSTL) Share Charts1 Year Tristel Chart |
|
1 Month Tristel Chart |
Intraday Tristel Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/3/2025 | 05:21 | The TRISTEL story | 3,459 |
| 24/7/2024 | 15:21 | Explosive Growth for the foreseeable future | 27 |
| 14/9/2018 | 13:56 | MRSA cleaner | 249 |
| 15/7/2015 | 12:01 | Tristel PLC: Cleaning up the sector | 340 |
| 03/1/2010 | 04:54 | tristel with charts | - |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 14:31:15 | 301.00 | 823 | 2,477.23 | O |
| 14:30:00 | 300.00 | 5,050 | 15,150.00 | O |
| 14:11:31 | 301.00 | 4 | 12.04 | O |
| 14:05:47 | 304.00 | 1,000 | 3,040.00 | O |
| 14:00:35 | 305.00 | 1 | 3.05 | O |
| Top Posts |
|---|
Posted at 27/3/2025 08:20 by Tristel Daily Update Tristel Plc is listed in the Med, Dental, Hosp Eq-whsl sector of the London Stock Exchange with ticker TSTL. The last closing price for Tristel was 305p.Tristel currently has 47,692,093 shares in issue. The market capitalisation of Tristel is £144,268,581. Tristel has a price to earnings ratio (PE ratio) of 22.23. This morning TSTL shares opened at 305p |
Posted at 25/2/2025 15:57 by gopher Tax rate rise result in eps decline as patent expiry impacts but otherwise much as usual with the USA taking time as usual but remains biggest opportunity.Dividend makes it attractive to growth and income investors as market rating has declined as share price has stagnated. |
Posted at 27/1/2025 22:15 by zimbtrader Awfully quiet here! I'm thinking the share price is looking rather tempting ahead of results in a few weeks.... |
Posted at 15/11/2024 09:49 by petewy Will Trump's tariffs hit this share or does TSTL make everything in the US?Views? |
Posted at 21/10/2024 10:16 by martinmc123 Tristel Plc, the manufacturer of infection prevention products for hospitals, posted its audited FY24 preliminary results and they were very impressive. FY24 turnover was up 16% to £41.9m, gross margin was up 2% to 80%. Adjusted pre-tax profit was up 32% to £8.2m with adjusted EPS up even more by 50% to 15.34p. This allowed management to increase the dividend per share by 29% to 13.52p. The robust performance also allowed the company to strengthen its balance sheet with cash and short term investments up to £11.8m from £9.5m...from WealthOraclewealthoracle.co.uk/d |
Posted at 15/10/2024 10:35 by philly cheesesteak I think all decent AIM stocks are going through the same painful process of derisking pre budget. I actually think CGT is a bigger driver than IHT at present, but who knows.SPA got sold down to 52p and has since bounced to 67p post results yesterday. FNX looks to have cleared the sellers there and is back to 242p Same over at W7L which tested £5 and has now bounced 10% FTC hit 61p last week and has since bounced 15% to 70p In general the more liquid stocks are clearing sellers faster, TSTL is illiquid and it's last material newsflow was nearly 3 months ago. If it wants to test 330p support before next week then bring it on. |
Posted at 06/9/2024 11:40 by zimbtrader Same pattern I've seen for several years seems to be in play again. Price drifts down in May / June, spikes up sharply following a trading update in July, drifts then sharply drops in September. Interim results date gets announced mid-September and the price heads north again as results in mid-October approaches.The only difference this year? A new CEO at the helm BUT we already have a fairly good idea what the interim results will be like. |
Posted at 28/7/2024 06:31 by markatkinson My dear friend Paul Kerin and I have just recorded an episode of the Desert Island Investor podcast where we discuss my holding in Tristel ( TSTL )- |
Posted at 22/7/2024 06:11 by z1co WOW !Very impressive 22 July 2024 Trading Update Revenues and pre-tax profits ahead of market expectations Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces a trading update for the year ended 30 June 2024, having delivered a strong trading performance ahead of market expectations and the Company's own performance targets. Demand for Tristel's infection prevention products continues to be very robust across all the Company's geographical markets which now include the USA and Canada. Consequently: · Revenues for the year were up 16.4% to £41.9m (FY 2023: £36.0m), ahead of market expectations and above the Company's performance target for revenue growth (an annual average of 10-15% over three years). · Adjusted profit before tax* will be no less than £8.0m, ahead of market expectations and 29% ahead of last year (FY 2023: £6.2m). · Tristel continues to be debt free and cash generative. Cash balances on 30 June 2024 were £11.6m (30 June 2023: £9.5m). Paul Swinney, CEO of Tristel plc, comments: "This is my last trading update before I hand over the reins to our incoming CEO in early September and I am delighted to report to shareholders that the business has delivered another strong trading performance and growth ahead of both analyst expectations and our own growth targets. |
Posted at 18/5/2024 14:29 by z1co Share price still on the downward trend , far too many selling these on any small rise £4.10 to £4.20 before the next trading update in July. |
Posted at 23/2/2021 17:25 by james188 There are many possible reasons for the recent TSTL share price activity (including IG recently deciding to withdraw from small cap stocks), but it does not matter much to medium and long term holders.Over time in recent years, the share price trajectory has been excellent and there is an obvious roll out strategy which is by no means solely reliant on North America. The company has barely got started in South-East Asia, has no presence in South America and is now projecting initial sales in India next month. The fact that the company remains debt free and relatively conservative are significant plusses for me. The end game may well be TSTL being acquired by a much larger fish, but why not enjoy the ride? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
